Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19). (Q44966920)
scientific article published on 9 August 2005
Language:
(P31) (Q13442814)
(P304) 105-112
(P407) (Q1860)
(P433) 2
(P478) 132
(P577) Tuesday, August 9, 2005
(P921) (Q42824827)
(Q268713)
(Q425745)
(P1433) (Q2081599)
(P1476) "Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19)." (language: en)
(P2093) M Herold
A Schulze
D Niederwieser
A Franke
H J Fricke
P Richter
M Freund
B Ismer
K Dachselt
C Boewer
V Schirmer
J Weniger
R Pasold
C Winkelmann
C Klinkenstein
M Schulze
H Arzberger
K Bremer
S Hahnfeld
A Schwarzer
C Müller
Chr Müller
East German Study Group Hematology and Oncology (OSHO)
(P2860) (Q69402210)
(Q28246957)
(Q34734956)
(Q70465384)
(Q44569025)
(Q74135370)
(Q45204128)
(Q77204553)
(Q53991694)
(Q44233737)
other details
description scientific article published on 9 August 2005

External Links